Microbiome and hepatitis C virus

Abstract

The progress of infectious diseases and the relationship between microbial communities is one of the main targets of multiple research studies over the last decade. This review illustrated the relationship between the microbiome and the hepatitis C virus during the disease stage until treatment. This review highlighted the alteration in the gut microbiome and its influence on disease progression. The design involved the studies screening the microbial communities in infected patients, especially in viral infection. As the drug efficacy and safety may also be involved during and after treatment, the review included studies on changes in the gut microbiome of patients after treatment. The future perspective of studying probiotics reflected the beneficial effects of probiotic bacteria and their potential use in reducing the side effects of HCV during infection and treatment.